Universal Health Services Inc (UHS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Universal Health Services Inc (UHS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3422
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Universal Health Services Inc (UHS) is a healthcare service provider the offers acute care and behavioral health services. The center provides services such as general and specialty surgery, internal medicine, obstetrics, oncology, diagnostic care, coronary care, emergency room care, radiology, paediatric services, pharmacy services and behavioral health services. It offers behavioral health integration solutions. UHS owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The center operates acute care hospitals in California, Florida, Nevada, Oklahoma, South Carolina, Texas and Washington. It also provides behavioral health services through its hospitals in Washington DC, Puerto Rico and Virgin Islands. The center has its presence in the US and the UK. UHS is headquartered in King of Prussia, Pennsylvania, the US.

Universal Health Services Inc (UHS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Universal Health Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Universal Health Services Acquires Palo Verde From Tucson Medical Center 10
Debt Offering 11
Universal Health Services to Raise USD300 Million in Public Offering of Notes Due 2022 11
Universal Health Services to Raise USD300 Million in Public Offering of Notes Due 2019 12
Asset Transactions 13
Strategic Behavioral Health Acquires Peak Behavioral Services Hospital From Universal Health Services 13
Universal Health Services Announces Sale Of Psychiatric Facility 15
Universal Health Completes Sale Of Auburn Regional Medical Center To MultiCare Health For US$98 Million 16
Universal Health Services Completes Sale Of Two Las Vegas Hospitals To Strategic Behavioral 17
Acquisition 18
Cygnet Health Acquires Alpha Hospitals from C&C Alpha for USD148.5 Million 18
Ascension Health to Acquire Four Middle Tennessee Hospitals from Capella Healthcare 19
Cygnet Health Acquires Orchard Portman House Hospital from Albion Ventures 20
Universal Health Services Acquires Cygnet Health Care for USD335 Million 21
Danshell Completes Acquisition Of Castlebeck For US$53 Million 22
Universal Health Services Completes Acquisition Of Ascend Health, Behavioral Healthcare Provider, For US$517 Million 23
Universal Health Services Inc – Key Competitors 25
Universal Health Services Inc – Key Employees 26
Universal Health Services Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Financial Announcements 30
Jul 25, 2018: Universal Health Services reports 2018 second quarter financial results 30
Apr 25, 2018: Universal Health Services Reports 2018 First Quarter Financial Results 34
Feb 28, 2018: Universal Health Services Reports 2017 Fourth Quarter And Full Year Earnings And 2018 Guidance 36
Oct 25, 2017: Universal Health Services Reports 2017 Third Quarter Financial Results and Revises 2017 Full Year Earnings Guidance 39
Jul 26, 2017: Universal Health Services Reports 2017 Second Quarter Financial Results And Revises 2017 Full Year Earnings Guidance 42
Apr 26, 2017: Universal Health Services Reports 2017 First Quarter Financial Results 45
Mar 01, 2017: Universal Health Services Reports 2016 Fourth Quarter And Full Year Earnings And 2017 Guidance 47
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Universal Health Services Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Universal Health Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Universal Health Services Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Universal Health Services Acquires Palo Verde From Tucson Medical Center 10
Universal Health Services to Raise USD300 Million in Public Offering of Notes Due 2022 11
Universal Health Services to Raise USD300 Million in Public Offering of Notes Due 2019 12
Strategic Behavioral Health Acquires Peak Behavioral Services Hospital From Universal Health Services 13
Universal Health Services Announces Sale Of Psychiatric Facility 15
Universal Health Completes Sale Of Auburn Regional Medical Center To MultiCare Health For US$98 Million 16
Universal Health Services Completes Sale Of Two Las Vegas Hospitals To Strategic Behavioral 17
Cygnet Health Acquires Alpha Hospitals from C&C Alpha for USD148.5 Million 18
Ascension Health to Acquire Four Middle Tennessee Hospitals from Capella Healthcare 19
Cygnet Health Acquires Orchard Portman House Hospital from Albion Ventures 20
Universal Health Services Acquires Cygnet Health Care for USD335 Million 21
Danshell Completes Acquisition Of Castlebeck For US$53 Million 22
Universal Health Services Completes Acquisition Of Ascend Health, Behavioral Healthcare Provider, For US$517 Million 23
Universal Health Services Inc, Key Competitors 25
Universal Health Services Inc, Key Employees 26
Universal Health Services Inc, Other Locations 27
Universal Health Services Inc, Subsidiaries 27

List of Figures
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Universal Health Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Universal Health Services Inc (UHS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xencor Inc (XNCR):企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company. It develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the t …
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • Commercial Bank International PSC:企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Toyota Tsusho Corp (8015):電力:M&Aディール及び事業提携情報
    Summary Toyota Tsusho Corp (Toyota Tsusho) is a diversified general trading and project management company. The company trades steel, aluminum, machinery, electronics, energy, chemicals, and other consumer products. It also provides passenger cars, buses, motorcycles, trucks, used vehicles, electron …
  • Clinical Laserthermia Systems AB (CLS B):企業の財務・戦略的SWOT分析
    Clinical Laserthermia Systems AB (CLS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Teijin Limited:企業の戦略・SWOT・財務情報
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dell Technologies Inc (DVMT):医療機器:M&Aディール及び事業提携情報
    Summary Dell Technologies, Inc. (Dell), is a provider of desktop personal computers, software and peripherals. The company designs, develops, manufactures, markets, sells and supports information technology infrastructure such as laptops, desktops, mobiles, workstations, storage devices and printers …
  • PT Pembangkitan Jawa-Bali:電力:M&Aディール及び事業提携情報
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Alexza Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • OraMetrix Inc-医療機器分野:企業M&A・提携分析
    Summary OraMetrix Inc (OraMetrix) is a healthcare technology company that provides 3-D technology solutions. The company offers orthodontic treatment system and digital lingual orthodontic system. Its product allows the use of precision digital tools throughout the orthodontic treatment process incl …
  • Synedgen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • Trina Solar Co Ltd (688599):企業の財務・戦略的SWOT分析
    Trina Solar Co Ltd (688599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Petro River Oil Corp (PTRC):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro River Oil Corp (Petro River), formerly Gravis Oil Corp, is an oil and gas company that offers independent energy solutions. The company operates in the exploration and development of conventional oil and gas assets. It develops projects in Osage County, Oklahoma; Kern County, Californi …
  • UDG Healthcare Plc (UDG)-医療機器分野:企業M&A・提携分析
    Summary UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities …
  • Steris PLC:企業の戦略・SWOT・財務分析
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Husky Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Husky Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Husky Energy Inc (Husky) is an integrated energy company. It operates across the oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bi …
  • Siem Offshore Inc (SIOFF):企業の財務・戦略的SWOT分析
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. It offers shipbuilding, ordering and delivery of new vessels, acquisition of modern second-hand …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆